# Sectoral Asset Management Inc 13F Q2 2026: $143 million

Sectoral Asset Management Inc reported $143 million in 13F securities across 82 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Contineum Therapeutics Inc at $11.9 million, 8.3% of the reported value. Since Q1 2026 it opened 15 new positions and exited 10.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $143,303,475
- Positions: 82
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1274413
- Form 13F file number: 028-10653
- CRD number: 110345
- Business address: 1010 Sherbrooke St., West Suite 1610, Montreal, H3A 2R7 Quebec, Canada
- SEC filing: [0001104659-26-096554](https://www.sec.gov/Archives/edgar/data/1274413/000110465926096554/0001104659-26-096554-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/sectoral-asset-management-inc-110345)

## Top 25 holdings by value

The largest of 82 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Contineum Therapeutics Inc](https://specstream.ai/data/institutional-holders/contineum-therapeutics-inc-21217b100) | CL A | 727,587 | $11.9 million | No change |
| [Shoulder Innovations Inc](https://specstream.ai/data/institutional-holders/shoulder-innovations-inc-82537j108) | COMMON STOCK | 430,407 | $8.7 million | No change |
| [Eli Lilly & Co](https://specstream.ai/data/institutional-holders/eli-lilly-co-532457108) | COM | 6,354 | $7.6 million | No change |
| [Unitedhealth Group Inc](https://specstream.ai/data/institutional-holders/unitedhealth-group-inc-91324p102) | COM | 13,235 | $5.5 million | -1,722 |
| [Johnson & Johnson](https://specstream.ai/data/institutional-holders/johnson-johnson-478160104) | COM | 18,218 | $4.6 million | No change |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 41,987 | $4 million | New |
| [Biontech Se](https://specstream.ai/data/institutional-holders/biontech-se-09075v102) | SPONSORED ADS | 41,869 | $3.9 million | +19,705 |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 78,310 | $3.7 million | New |
| [Dexcom Inc](https://specstream.ai/data/institutional-holders/dexcom-inc-252131107) | COM | 50,756 | $3.4 million | +27,525 |
| [Arcus Biosciences Inc](https://specstream.ai/data/institutional-holders/arcus-biosciences-inc-03969f109) | COM | 110,870 | $3.4 million | +65,800 |
| [Amgen Inc](https://specstream.ai/data/institutional-holders/amgen-inc-031162100) | COM | 9,210 | $3.3 million | No change |
| [Summit Therapeutics Inc](https://specstream.ai/data/institutional-holders/summit-therapeutics-inc-86627t108) | COM | 220,180 | $3.2 million | +150,565 |
| [Irhythm Holdings Inc](https://specstream.ai/data/institutional-holders/irhythm-holdings-inc-450056106) | COM | 26,070 | $3.1 million | New |
| [Abbvie Inc](https://specstream.ai/data/institutional-holders/abbvie-inc-00287y109) | COM | 12,200 | $3.1 million | No change |
| [Merck & Co Inc](https://specstream.ai/data/institutional-holders/merck-co-inc-58933y105) | COM | 21,480 | $2.8 million | No change |
| [Arrivent Biopharma Inc](https://specstream.ai/data/institutional-holders/arrivent-biopharma-inc-04272n102) | COM | 79,043 | $2.7 million | +49,030 |
| [Vertex Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/vertex-pharmaceuticals-inc-92532f100) | COM | 5,432 | $2.7 million | -1,575 |
| [Argenx Se](https://specstream.ai/data/institutional-holders/argenx-se-04016x101) | SPONSORED ADR | 2,831 | $2.6 million | -733 |
| [Gilead Sciences Inc](https://specstream.ai/data/institutional-holders/gilead-sciences-inc-375558103) | COM | 20,620 | $2.6 million | -6,870 |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 23,216 | $2.5 million | +3,548 |
| [Tectonic Therapeutic Inc](https://specstream.ai/data/institutional-holders/tectonic-therapeutic-inc-878972108) | COM | 71,009 | $2.4 million | +51,950 |
| [Intuitive Surgical Inc](https://specstream.ai/data/institutional-holders/intuitive-surgical-inc-46120e602) | COM NEW | 5,850 | $2.3 million | +600 |
| [Immatics N.V](https://specstream.ai/data/institutional-holders/immatics-n-v-n44445109) | SHS | 224,928 | $2.3 million | +158,098 |
| [Stryker Corporation](https://specstream.ai/data/institutional-holders/stryker-corporation-863667101) | COM | 7,129 | $2.2 million | +1,255 |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 119,923 | $2.2 million | New |

## New positions in Q2 2026

15 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 41,987 | $4 million |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 78,310 | $3.7 million |
| [Irhythm Holdings Inc](https://specstream.ai/data/institutional-holders/irhythm-holdings-inc-450056106) | COM | 26,070 | $3.1 million |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 119,923 | $2.2 million |
| [Crescent Biopharma Inc.](https://specstream.ai/data/institutional-holders/crescent-biopharma-inc-g2545c104) | COM | 121,300 | $2.2 million |
| [Pulse Biosciences Inc](https://specstream.ai/data/institutional-holders/pulse-biosciences-inc-74587b101) | COM | 67,895 | $1.9 million |
| [Alphatec Hldgs Inc](https://specstream.ai/data/institutional-holders/alphatec-hldgs-inc-02081g201) | COM NEW | 185,900 | $1.6 million |
| [Transmedics Group Inc](https://specstream.ai/data/institutional-holders/transmedics-group-inc-89377m109) | COM | 21,950 | $1.5 million |
| [CVS Health Corp](https://specstream.ai/data/institutional-holders/cvs-health-corp-126650100) | COM | 13,000 | $1.3 million |
| [Centene Corp Del](https://specstream.ai/data/institutional-holders/centene-corp-del-15135b101) | COM | 12,000 | $770,280 |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 2,570 | $685,470 |
| [Humana Inc](https://specstream.ai/data/institutional-holders/humana-inc-444859102) | COM | 1,250 | $497,299 |
| [Tempus AI Inc](https://specstream.ai/data/institutional-holders/tempus-ai-inc-88023b103) | CL A | 3,880 | $224,768 |
| [Corbus Pharmaceuticals Hldgs](https://specstream.ai/data/institutional-holders/corbus-pharmaceuticals-hldgs-21833p301) | COM NEW | 20,000 | $187,600 |
| [Engene Therapeutics Inc](https://specstream.ai/data/institutional-holders/engene-therapeutics-inc-29286x101) | COM | 21,700 | $37,541 |

## Positions exited in Q2 2026

10 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Evommune Inc](https://specstream.ai/data/institutional-holders/evommune-inc-30054y107) | COM SHS | 589,005 | $13.5 million |
| [Rapport Therapeutics Inc](https://specstream.ai/data/institutional-holders/rapport-therapeutics-inc-75383l102) | COM | 25,421 | $835,005 |
| [Boundless Bio Inc](https://specstream.ai/data/institutional-holders/boundless-bio-inc-10170a100) | COM | 678,574 | $746,431 |
| Ascendis Pharma A/S | SPONSORED ADR | 2,800 | $728,276 |
| [Uniqure NV](https://specstream.ai/data/institutional-holders/uniqure-nv-n90064101) | SHS | 29,245 | $499,411 |
| [Alignment Healthcare Inc](https://specstream.ai/data/institutional-holders/alignment-healthcare-inc-01625v104) | COM | 26,911 | $474,172 |
| [Radnet Inc](https://specstream.ai/data/institutional-holders/radnet-inc-750491102) | COM | 7,999 | $447,064 |
| [Inspire Med Sys Inc](https://specstream.ai/data/institutional-holders/inspire-med-sys-inc-457730109) | COM | 7,225 | $372,666 |
| [Neurocrine Biosciences Inc](https://specstream.ai/data/institutional-holders/neurocrine-biosciences-inc-64125c109) | COM | 2,300 | $343,841 |
| [Omada Health Inc](https://specstream.ai/data/institutional-holders/omada-health-inc-68170a108) | COM | 25,620 | $322,043 |

## Also on SpecStream

- [Sectoral Asset Management Inc Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1274413/000110465926096554/0001104659-26-096554-index.htm)
- [Sectoral Asset Management Inc investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/sectoral-asset-management-inc-110345)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Disability law firms in the United States](https://specstream.ai/data/businesses/disability-law-firms/united-states)
- [B2B advertising and marketing companies in the United States](https://specstream.ai/data/businesses/b2b-advertising-and-marketing-companies/united-states)
- [Southern American restaurants in the United States](https://specstream.ai/data/businesses/southern-american-restaurants/united-states)
- [Motorcycle manufacturers in the United States](https://specstream.ai/data/businesses/motorcycle-manufacturers/united-states)
- [Garage door companies in the United States](https://specstream.ai/data/businesses/garage-door-companies/united-states)
- [Cement suppliers in the United States](https://specstream.ai/data/businesses/cement-suppliers/united-states)
